Science Applications International financials
$130.93−1.27%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY26 Jan 30 | FY25 Jan 31 | FY24 Feb 2 | FY23 Feb 3 | FY22 Jan 28 | FY21 Jan 29 | FY20 Jan 31 | FY19 Feb 1 | FY18 Feb 2 | FY17 Feb 3 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.26B | $7.48B | $7.44B | $7.70B | $7.39B | $7.06B | $6.38B | $4.66B | $4.45B | $4.44B |
| Gross profit | $872.0M | $892.0M | $872.0M | $888.0M | $859.0M | $792.0M | $706.0M | $464.0M | $411.0M | $439.0M |
| Gross margin | 12.0% | 11.9% | 11.7% | 11.5% | 11.6% | 11.2% | 11.1% | 10.0% | 9.2% | 9.9% |
| Operating income | $522.0M | $553.0M | $499.0M | $488.0M | $516.0M | $390.0M | $370.0M | $220.0M | $256.0M | $263.0M |
| Net income | $358.0M | $362.0M | $477.0M | $300.0M | $277.0M | $209.0M | $226.0M | $137.0M | $179.0M | $143.0M |
| Net margin | 4.9% | 4.8% | 6.4% | 3.9% | 3.7% | 3.0% | 3.5% | 2.9% | 4.0% | 3.2% |
| Diluted EPS | $7.70 | $7.17 | $8.88 | $5.38 | $4.77 | $3.56 | $3.83 | $3.11 | $4.02 | $3.12 |
| EBITDA | $671.0M | $693.0M | $641.0M | $658.0M | $681.0M | $608.0M | $549.0M | $353.0M | $302.0M | $326.0M |
| Operating cash flow | $609.0M | $494.0M | $396.0M | $532.0M | $518.0M | $755.0M | $458.0M | $184.0M | $217.0M | $273.0M |
| Free cash flow | $577.0M | $458.0M | $369.0M | $507.0M | $482.0M | $709.0M | $437.0M | $156.0M | $195.0M | $258.0M |
| Diluted shares | 46.5M | 50.5M | 53.7M | 55.8M | 58.1M | 58.7M | 59.0M | 44.1M | 44.5M | 45.9M |
Balance sheet
| Period end | Jan 30 | Jan 31 | Feb 2 | Feb 3 | Jan 28 | Jan 29 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $182.0M | $56.0M | $94.0M | $109.0M | $106.0M | $171.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $2.49B | $2.22B | $2.10B | $2.37B | $2.52B | $2.52B |
| Total assets | $5.35B | $5.25B | $5.31B | $5.54B | $5.75B | $5.72B |
| Total liabilities | $3.85B | $3.67B | $3.53B | $3.84B | $4.12B | $4.17B |
| Shareholders' equity | $1.50B | $1.58B | $1.78B | $1.70B | $1.63B | $1.55B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology